Prothena Corporation plc (PRTA)
Market Closed
16 Oct, 08:00 PM
$
8. 35
-0.15
-1.7647%
$
428.66M Market Cap
- P/E Ratio
- Div Yield
670,300 Volume
-2.73 Eps
$ 8.5
Previous Close 
Want to track PRTA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate
Prothena (PRTA) announces that Bristol Myers is exercising its option for the second time, thereby in-licensing exclusive global rights for PRX019 to potentially treat neurodegenerative diseases.
Zacks | 2 years ago
2026 © Marketlog. All Rights Reserved.
